MedTrace Logo

Vitamin D Deficiency and Asthma Exacerbation

NCT02661191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2016-01-22

No results posted yet for this study

Summary

The study aim is in two phases. First phase: to evaluate the influence of vitamin D deficiency on asthma severity, degree of airway obstruction and frequency of asthma exacerbations. Second phase: to evaluate if in patients with vitamin D deficiency (25-OH vitamin D levels below 20 ng/ml), vitamin D supplementation decreases the number of disease exacerbations.

Conditions

  • Asthma
  • Vitamin D Deficiency
  • Disease Exacerbation

Interventions

DRUG

oral cholecalciferol

Inhaled corticosteroids and long-acting beta-agonists, salbutamol

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Caterina B Bucca, MD · Dept. Medical Science, University of Turin

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-03-31
Completion
2014-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02661191 on ClinicalTrials.gov